Concord Drugs Limited
Stock

Concord Drugs Limited

Pharmaceuticals
Share price
73
Market cap
₹107 Cr
1Y return
43%

A pharmaceutical manufacturer incorporated in 1995, Concord Drugs produces licensed drugs based on approved formulations for the Indian market. The company operates across multiple therapeutic categories, manufacturing both generic and branded medications. Its distinctive strength lies in its vertically integrated operations spanning drug formulation, quality production, and distribution through established pharmaceutical channels across India's healthcare ecosystem.

Track the whales in Concord Drugs Limited

Get alerted the moment a top investor buys or sells.

Get started
Concord Drugs — investor holdings · WhaleWatch